Re: RESEARCH - Enbrel safe and effective long term for RA

[Guest guest]

Thanks , that's the best news I've had in a while

Kate f

Sent from my iPhone

On Nov 7, 2010, at 9:15 AM, <Rheumatoid.Arthritis.Support@...>

wrote:

> Medscape

> From Reuters Health Information

>

> Etanercept Safe and Effective Long Term for Rheumatoid Arthritis

>

> NEW YORK (Reuters Health) Nov 02 - Treatment with etanercept (Enbrel)

> beyond 10 years is safe and effective for patients with early and

> long-standing rheumatoid arthritis (RA), according to findings

> published in the October 18th online Arthritis Care & Research.

>

> Several studies have demonstrated the safety and efficacy of the tumor

> necrosis factor (TNF) blocker etanercept in the treatment of patients

> with early rheumatoid arthritis or moderate to severe long-standing

> rheumatoid arthritis.

>

> Dr. E. Weinblatt from Harvard Medical School, Brigham and

> Women's Hospital, Boston, Massachusetts and colleagues evaluated the

> long-term safety of etanercept in an open-label extension study of 468

> early RA patients and 581 long-standing RA patients.

>

> One hundred sixty-three early RA patients and 264 long-standing RA

> patients were followed through year 10, and the median duration of

> etanercept exposure was 7.2 years for early RA patients and 6.3 years

> for long-standing RA patients.

>

> The exposure-adjusted rate of serious adverse events per 100

> patient-years was 12.1 for early RA patients and 18.4 for

> long-standing RA patients.

>

> ************************************************

> Read the full article here:

>

> http://www.medscape.com/viewarticle/731799

>

>

> Not an MD

>

[Guest guest]

To your good health, Kate!

Not an MD

On Sun, Nov 7, 2010 at 8:20 AM, Kate Fair <kalfoley@...> wrote:

> Thanks , that's the best news I've had in a while

> Kate f

[Guest guest]

That is great news, thanks .

Sent via DROID on Verizon Wireless

[ ] RESEARCH - Enbrel safe and effective long term for RA

Medscape

From Reuters Health Information

Etanercept Safe and Effective Long Term for Rheumatoid Arthritis

NEW YORK (Reuters Health) Nov 02 - Treatment with etanercept (Enbrel)

beyond 10 years is safe and effective for patients with early and

long-standing rheumatoid arthritis (RA), according to findings

published in the October 18th online Arthritis Care & Research.

Several studies have demonstrated the safety and efficacy of the tumor

necrosis factor (TNF) blocker etanercept in the treatment of patients

with early rheumatoid arthritis or moderate to severe long-standing

rheumatoid arthritis.

Dr. E. Weinblatt from Harvard Medical School, Brigham and

Women's Hospital, Boston, Massachusetts and colleagues evaluated the

long-term safety of etanercept in an open-label extension study of 468

early RA patients and 581 long-standing RA patients.

One hundred sixty-three early RA patients and 264 long-standing RA

patients were followed through year 10, and the median duration of

etanercept exposure was 7.2 years for early RA patients and 6.3 years

for long-standing RA patients.

The exposure-adjusted rate of serious adverse events per 100

patient-years was 12.1 for early RA patients and 18.4 for

long-standing RA patients.

************************************************

Read the full article here:

http://www.medscape.com/viewarticle/731799

Not an MD

[Guest guest]

Great news! Thanks Vivian

[ ] RESEARCH - Enbrel safe and effective long term for RA

Medscape

From Reuters Health Information

Etanercept Safe and Effective Long Term for Rheumatoid Arthritis

NEW YORK (Reuters Health) Nov 02 - Treatment with etanercept (Enbrel) beyond

10 years is safe and effective for patients with early and long-standing

rheumatoid arthritis (RA), according to findings published in the October

18th online Arthritis Care & Research.

Several studies have demonstrated the safety and efficacy of the tumor

necrosis factor (TNF) blocker etanercept in the treatment of patients with

early rheumatoid arthritis or moderate to severe long-standing rheumatoid

arthritis.

Dr. E. Weinblatt from Harvard Medical School, Brigham and Women's

Hospital, Boston, Massachusetts and colleagues evaluated the long-term

safety of etanercept in an open-label extension study of 468 early RA

patients and 581 long-standing RA patients.

One hundred sixty-three early RA patients and 264 long-standing RA patients

were followed through year 10, and the median duration of etanercept

exposure was 7.2 years for early RA patients and 6.3 years for long-standing

RA patients.

The exposure-adjusted rate of serious adverse events per 100 patient-years

was 12.1 for early RA patients and 18.4 for long-standing RA patients.

************************************************

Read the full article here:

http://www.medscape.com/viewarticle/731799

Not an MD